Viewing Study NCT02608359


Ignite Creation Date: 2025-12-24 @ 2:27 PM
Ignite Modification Date: 2026-04-23 @ 3:58 AM
Study NCT ID: NCT02608359
Status: WITHDRAWN
Last Update Posted: 2025-02-03
First Post: 2015-11-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer
Sponsor: Johnson & Johnson Private Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module